Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

about

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy Drug discovery in prostate cancer mouse models.Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.

P2860

Q35216973-AD7E414A-C2A7-41F5-A042-EB4CD277264A Q38509211-6AF98A2E-F24C-46D3-92FD-BFC8C8E13AD6 Q38986804-66D4510F-FF03-40A1-9510-733601820FEF

P2860

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

Item

http://www.wikidata.org/entity/Q45885542

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@en

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@nl

type

Item

label

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@en

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@nl

prefLabel

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@en

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@nl

P1476

Therapeutic effects of adoptiv ...... a mouse prostate cancer model.

@en

P2093

Kumon H

http://www.w3.org/2001/XMLSchema#string

Kusaka N

http://www.w3.org/2001/XMLSchema#string

Mouraviev V

http://www.w3.org/2001/XMLSchema#string

Saika T

http://www.w3.org/2001/XMLSchema#string

Satoh T

http://www.w3.org/2001/XMLSchema#string

Thompson TC

http://www.w3.org/2001/XMLSchema#string

Timme TL

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

Therapeutic targets for metastatic prostate cancer.

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.

P2888

sj.cgt.7700872

P304

91-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7700872

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7694021

http://www.w3.org/2001/XMLSchema#string

P6179

1035181903

http://www.w3.org/2001/XMLSchema#string

P698

16052232

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

about

P2860

P2860

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921